Toxic leukoencephalopathy due to inhalational heroin abuse
Samir Kashyap, Gohar Majeed, Ira Bowen, Yancey Beamer, Dan Miulli
Department of Neurosurgery, Arrowhead Regional Medical Center, Colton; Department of Neurosurgery, Riverside University Health System, Riverside, CA, USA
Correspondence Address:
Samir Kashyap, Department of Neurosurgery, Arrowhead Regional Medical Center, Colton, CA, 400 N Pepper Ave, Colton, CA 92324; Department of Neurosurgery, Riverside University Health System, Riverside, CA, 26520 Cactus Ave, Moreno, Valley, CA 92555 USA
 Source of Support: None, Conflict of Interest: None DOI: 10.4103/aian.AIAN_446_18
|
Heroin-induced spongiform leukoencephalopathy (HSLE) is a rare condition that is strongly associated with heroin vapor inhalation which has become a popular method among heroin addicts because it poses a less immediate danger to the user and makes the drug much easier to use. We present a case of a 22-year-old male who presented with dysarthria and cerebellar symptoms starting, after 3 months of heroin inhalation. Diagnosis was confirmed to be HSLE after extensive diagnostic testing. HSLE is a rare complication of which the pathogenesis is poorly understood. Clinical history and characteristic findings on magnetic resonance imaging (diffuse, symmetric T2-hyperintensity, and diffusion restriction in frontal, parietal, occipital lobs, basal ganglia, and superior cerebellum) are diagnostic; however, care should be taken to exclude other etiologies. Treatment is primarily supportive; however, there is anecdotal evidence that coenzyme Q10 may be of benefit. The growing number of victims of the opioid crisis requires that physicians be aware of and counsel patients on the devastating neurological complications that can occur with abuse of these drugs.
|